Single Cell Analysis in Next-Generation Sequencing Markets (Market Size and Forecast, Segment Breakouts, Secondary Research), 2022-2027 focuses on the market for single cell genomics products - the hardware, service of the hardware, software, and consumables including for the sequencing step and other types of downstream analysis. It discusses trends, challenges, strategies, companies, and products, and provides estimates of market share and revenue growth for the market. The competitive situation, deals, and products are covered in respective chapters. Historical data for 2021 is provided, with forecast data spanning 2022-2027.
The provides the most current market research into single cell genomics and the companies that participate in this market. Some of the key market trends covered in the report include the following:
Companies Profiled include:
The provides the most current market research into single cell genomics and the companies that participate in this market. Some of the key market trends covered in the report include the following:
- Increasing number of cells profiled
- Multi-omics focus, products
- Spatial/in situ genomics, transcriptomics
- Data analysis challenges; software and IT introductions
- Convergence of technological advances
- Litigation
Companies Profiled include:
- 10X Genomics
- Bio-Rad
- Dolomite Bio
- Fluidigm
- Illumina
- Mission Bio
- Qiagen
- Takara Bio
Table of Contents
Chapter 1: Executive Summary
Chapter 2: Introduction
Chapter 3: Market Analysis
Chapter 4: Company Profiles
Companies Mentioned
- 10x Genomics
- Bio-Rad
- Dolomite Bio
- Fluidigm
- Illumina
- Mission Bio
- Qiagen
- Takara Bio
